Xanthomatous lesions on tendons - Causes, Treatment & When to See a Doctor

```html

What is Xanthomatous lesions on tendons?

Xanthomatous lesions on tendons are yellow‑to‑orange, soft‑to‑firm nodules that develop within or just above the fibrous tissue of a tendon. The word “xanthoma” comes from the Greek xanthós meaning “yellow,” reflecting the lesion’s characteristic color. These deposits are composed mainly of cholesterol‑rich lipids that have been taken up by macrophages (foam cells) and accumulated in the connective tissue. When they appear on tendons, they are most commonly seen on the Achilles tendon, extensor tendons of the hands, and the tendons around the elbow and shoulder. Though they are usually painless, they can become tender, limit motion, or be a cosmetic concern.

Common Causes

Several metabolic, genetic, and systemic conditions can lead to tendon xanthomas. The most frequent causes are:

• Familial hypercholesterolemia (FH) – an autosomal‑dominant disorder causing markedly elevated LDL‑cholesterol.
• Familial combined hyperlipidemia – high LDL and triglycerides with normal or low HDL.
• Type III hyperlipoproteinemia (Dysbetalipoproteinemia) – defective ApoE leading to cholesterol‑rich remnant particles.
• Secondary hyperlipidemia – due to uncontrolled diabetes, hypothyroidism, chronic kidney disease, or certain medications (e.g., corticosteroids, protease inhibitors).
• Cholesterol‑controlled metabolic syndromes – obesity, metabolic syndrome, and insulin resistance.
• Familial sitosterolemia – rare plant sterol absorption disorder that can cause tendon xanthomas.
• Cholesterol‑laden inflammatory disorders – such as systemic lupus erythematosus or rheumatoid arthritis when treated with long‑term steroids.
• Trauma or repeated micro‑injury – injury may promote local lipid deposition in predisposed individuals.
• Rare genetic lipid storage diseases – e.g., Niemann‑Pick disease type C.
• Medication‑induced lipid changes – certain antipsychotics, beta‑blockers, and immunosuppressants.

Associated Symptoms

While a tendon xanthoma itself may be the only sign, it frequently co‑exists with other clinical features depending on the underlying cause:

• Hypercholesterolemia‑related findings – premature coronary artery disease, angina, or myocardial infarction.
• Arcus senilis (a gray‑white ring around the cornea) especially in FH.
• Xanthelasma on the eyelids.
• Increased tendon thickness or tenderness that may mimic tendinitis.
• Skin‑colored papules on the elbows, knees, or buttocks (eruptive xanthomas).
• Family history of early‑onset heart disease or known lipid disorders.
• Systemic symptoms of the associated disease – e.g., fatigue and weight gain in hypothyroidism.

When to See a Doctor

Prompt evaluation is advisable if you notice any of the following:

• New, enlarging, or painful nodules on a tendon, especially the Achilles or hand extensors.
• Associated skin changes (yellow plaques, xanthelasma) or a family history of high cholesterol.
• Chest discomfort, shortness of breath, or unexplained fatigue – possible sign of heart disease.
• Rapid growth of a lesion that becomes hard, ulcerates, or drains fluid.
• Any sudden loss of function or severe pain after an injury.

Diagnosis

Diagnosing tendon xanthomas involves a combination of clinical assessment, laboratory testing, and imaging.

1. Clinical Examination

• Visual inspection for yellow‑orange nodules.
• Palpation to assess size, consistency, and tenderness.
• Family history and review of cardiovascular risk factors.

2. Laboratory Tests

• Lipid panel – total cholesterol, LDL‑C, HDL‑C, triglycerides.
• Genetic testing for FH (LDLR, APOB, PCSK9 mutations) if lipid levels are markedly abnormal.
• Thyroid function tests (TSH, free T4) to rule out secondary hyperlipidemia.
• Fasting glucose/HbA1c if diabetes is suspected.

3. Imaging Studies

• Ultrasound – readily shows hyperechoic, heterogeneous thickening of the tendon.
• Magnetic Resonance Imaging (MRI) – detailed view of intra‑tendinous deposits and helps differentiate from neoplasms.
• CT scan – useful for assessing calcification within the lesion.

4. Histopathology (Rare)

If the diagnosis remains unclear, a core needle or excisional biopsy can be performed. Microscopy reveals foam cells, cholesterol clefts, and sometimes fibrous tissue proliferation.

Treatment Options

The primary aim is to reduce lipid accumulation, prevent cardiovascular complications, and address cosmetic or functional concerns.

1. Lipid‑Lowering Therapy

• Statins (e.g., atorvastatin, rosuvastatin) – first‑line agents that lower LDL‑C by 30‑50%.
• Ezetimibe – added when statins alone are insufficient.
• PCSK9 inhibitors (evolocumab, alirocumab) – especially in FH or when statin intolerance occurs.
• Bile‑acid sequestrants or fibric acid derivatives for mixed dyslipidemia.

Effective lipid control can stabilize or even shrink existing xanthomas over months to years (Mayo Clinic, 2023).<sup>1</sup>

2. Lifestyle Modifications

• Adopt a heart‑healthy diet: low in saturated fat, trans‑fat, and cholesterol; rich in fruits, vegetables, whole grains, and omega‑3 fatty acids.
• Achieve and maintain a healthy weight (BMI < 25 kg/m²).
• Engage in moderate‑intensity aerobic exercise ≥150 min/week.
• Quit smoking and limit alcohol intake.

3. Surgical / Procedural Options

• Excisional surgery – removal of large, painful, or cosmetically distressing lesions. Requires careful tendon repair to avoid weakness.
• Laser therapy or radiofrequency ablation – emerging minimally invasive techniques with limited data.
• Procedures are usually reserved for patients whose lesions do not regress with medical therapy.

4. Symptom‑Focused Care

• Non‑steroidal anti‑inflammatory drugs (NSAIDs) for occasional tenderness.
• Physical therapy to maintain tendon flexibility and strength.
• Compression sleeves or orthotics for Achilles tendon involvement.

Prevention Tips

Because most tendon xanthomas result from chronic lipid abnormalities, prevention focuses on cardiovascular health:

• Screen lipid profiles at least once every 5 years for adults; earlier and more frequent testing for those with a family history of FH or early heart disease.
• Follow the CDC’s heart‑healthy lifestyle guidelines.
• If you have a diagnosed lipid disorder, adhere strictly to prescribed medication and attend regular follow‑up labs.
• Control secondary contributors – maintain euthyroid status, manage diabetes, and avoid excess alcohol.
• Educate family members; cascade screening of first‑degree relatives can identify FH before lesions develop.

Emergency Warning Signs

---

References

1. Mayo Clinic. “Xanthomas: Causes, Symptoms, and Treatment.” Updated 2023. https://www.mayoclinic.org
2. National Heart, Lung, and Blood Institute (NHLBI). “Familial Hypercholesterolemia.” 2022. https://www.nhlbi.nih.gov
3. American Heart Association. “Understanding Lipid Disorders.” 2021. https://www.heart.org
4. World Health Organization. “Guidelines on the Management of Dyslipidaemias.” 2020. https://www.who.int
5. Cleveland Clinic. “Tendon Xanthomas: Appearance, Causes, and Treatment.” 2022. https://my.clevelandclinic.org
6. European Atherosclerosis Society. “Genetic Testing for Familial Hypercholesterolemia.” 2021. https://eas-soc.org

```